Approps continuing resolution
This article was originally published in The Tan Sheet
Executive Summary
House passes H.J. Res 13 on Jan. 28, Senate the day after, extending continuing appropriations for FY 2003 through Feb. 7 while government awaits resolution of omnibus approps bill (1"The Tan Sheet" Jan. 27, 2003, p. 2)...
You may also be interested in...
Omnibus bill clears Senate
Amendment that would allocate $10 mil. in FDA funding "for the continuance of methamphetamine reduction efforts" passes Senate by voice vote Jan. 23. Proposed by Sen. Charles Grassley (R-Iowa), amendment is one of more than 200 considered by upper chamber before it passed omnibus spending package (H J Res 2) the same day in a 69-29 vote. Measure would provide FDA with $1.63 bil. in FY 2003, of which $412.4 mil. would be allocated to CFSAN, $426.2 mil. to CDER. NCCAM would receive $114.1 mil., roughly $9 mil. above House-approved level. Next step is conference with lower chamber, which passed its omnibus package Jan. 8; Hill sources say conference process could be resolved by the Presidents' Day recess, although Congress faces "tremendous hurdles"...
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.